Effectiveness of Brief Intervention in Primary Care for Diverse Young People (Chat)
RAND · with AltaMed Health Services Corporation, University of Pittsburgh Medical Center · NCT06699251
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 12–19 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 500
- US sites recruiting
- 3
- Study start
- April 28, 2025
- Record last updated
- September 9, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Brief motivational interviewing intervention to address alcohol use among diverse teens 12-17.
Being studied: Chat; Enhanced Usual Care
Conditions: Adolescent Drinking; Cannabis Use
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- receive health care at one of two participating health systems
- aged 12-17
- screen positive for being at risk for alcohol or cannabis use using the CRAFFT
Exclusion Criteria
- if they don't meet the inclusion criteria, they will be excluded
Recruiting US locations
AltaMed Health Services
Commerce, CA 90022
Site contact: Sandra Pisano · 888-499-9303 · SPisano@altamed.org
Valley Community Healthcare
North Hollywood, CA 91605
Site contact: Jill Halper, MD · 818-763-8836 · jhalper@vchcare.org
University of Pittsburgh Medical Center Children's Hospital
Pittsburgh, PA 15213
Site contact: Ana Radovic · 412-692-6677 · Ana.Radovic@chp.edu
Study contacts (from the official record)
- Elizabeth J D'Amico, PhD · 3103930411 · damico@rand.org
- Michael J Woodward · 3103930411 · michaelw@rand.org
Similar studies in California
All healthy volunteers studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- Rialto, CA + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Lake Forest, CA + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Phase 1 Study of SBS-147 in Healthy Adults
Sparian Biosciences, Inc
- Location
- Cypress, CA
- Eligibility basics
- Ages 18–55